Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic CancersPablo D. García, Matthew T. Burger, John L. Langowski et al.|Clinical Cancer Research|2014Cited by 111
Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC DesignJamie Jarusiewicz, Zoran Ranković, Satoshi Yoshimura et al.|ACS Medicinal Chemistry Letters|2023Cited by 65
Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell linesGisele Nishiguchi, Zoran Ranković, Darcie J. Miller et al.|Nature Communications|2024Cited by 50
Data from Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic CancersPablo D. García, Matthew T. Burger, John L. Langowski et al.|Unknown|2023Cited by 0
Data from Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic CancersPablo D. García, Matthew T. Burger, John L. Langowski et al.|Unknown|2023Cited by 0